AFP and hepatocellular carcinoma: The area under the working characteristic curve of AAFP% was 0.796, that of ADCP% was 0.912, that of AAFP% + ADCP% combined was 0.921, and that of AAFP% + ADCP% had the most significant diagnostic value.<h4>Conclusions</h4>A combined analysis of serum AFP and DCP levels before and after TACE can be used to evaluate the therapeutic effect of TACE in patients with hepatocellular carcinoma.